0000950170-23-070382.txt : 20231214
0000950170-23-070382.hdr.sgml : 20231214
20231214160507
ACCESSION NUMBER: 0000950170-23-070382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231212
FILED AS OF DATE: 20231214
DATE AS OF CHANGE: 20231214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sherman Matthew L
CENTRAL INDEX KEY: 0001325710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 231487088
MAIL ADDRESS:
STREET 1: C/O DECIPHERA PHARMACEUTICALS, INC.
STREET 2: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
ownership.xml
4
X0508
4
2023-12-12
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001325710
Sherman Matthew L
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
false
true
false
false
EVP & Chief Medical Officer
false
Common Stock
2023-12-12
4
A
false
8244
A
99306
D
Common Stock
2023-12-13
4
S
false
2792
15.3671
D
96514
D
On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On December 12, 2023, the Issuer's Compensation Committee confirmed that performance criteria one had been met, resulting in the vesting of 8,244 RSUs.
Includes 434 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on November 14, 2023.
This sale was to cover tax liabilities in the vesting of RSUs.
/s/ Jeffrey M. Held, Attorney-in-Fact
2023-12-14